Shopping Cart 0
Cart Subtotal
AED 0

Stentys SA (STNT) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company's products include xposition S self-applying stent, mistent biodegradable sirolimus release stent and stentys AC thromboaspiration catheter. Its self apposing drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

Stentys SA (STNT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Stentys SA, Medical Equipment, Deal Details 10

Partnerships 10

Stentys Enters into Distribution Agreement with Micell for MiStent SES 10

Equity Offering 11

Stentys Raises USD14.6 Million in Rights Offering of Shares 11

Stentys Raises USD14.3 Million in Rights Offering of Shares 12

Stentys Announced Private Placement Of Shares 14

Stentys Completes Rights Issue Of Shares For USD 47.3 Million 15

Stentys Completes Private Placement Of Shares For USD 11 Million 16

Acquisition 17

Stentys Acquire Minvasys for USD9.2 Million 17

Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18

Stentys SA-Key Competitors 19

Stentys SA-Key Employees 20

Stentys SA-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Financial Announcements 22

Oct 11, 2018: STENTYS: Financial Information for the Third Quarter of 2018 22

Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 23

Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 24

Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 25

Oct 02, 2017: STENTYS: 2017 half-year results 26

Jul 12, 2017: STENTYS: Revenues Of EUR1.7 Million in the Second Quarter Of 2017 27

Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 28

Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at EUR7.3 Million 29

Corporate Communications 30

Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 30

Product News 31

May 24, 2017: STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Stentys SA, Medical Equipment, Key Facts, 2017 2

Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Deals By Market, 2012 to YTD 2018 8

Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Stentys Enters into Distribution Agreement with Micell for MiStent SES 10

Stentys Raises USD14.6 Million in Rights Offering of Shares 11

Stentys Raises USD14.3 Million in Rights Offering of Shares 12

Stentys Announced Private Placement Of Shares 14

Stentys Completes Rights Issue Of Shares For USD 47.3 Million 15

Stentys Completes Private Placement Of Shares For USD 11 Million 16

Stentys Acquire Minvasys for USD9.2 Million 17

Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18

Stentys SA, Key Competitors 19

Stentys SA, Key Employees 20

Stentys SA, Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Stentys SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company's products include xposition S self-applying stent, mistent biodegradable sirolimus release stent and stentys AC thromboaspiration catheter. Its self apposing drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

Stentys SA (STNT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Stentys SA, Medical Equipment, Deal Details 10

Partnerships 10

Stentys Enters into Distribution Agreement with Micell for MiStent SES 10

Equity Offering 11

Stentys Raises USD14.6 Million in Rights Offering of Shares 11

Stentys Raises USD14.3 Million in Rights Offering of Shares 12

Stentys Announced Private Placement Of Shares 14

Stentys Completes Rights Issue Of Shares For USD 47.3 Million 15

Stentys Completes Private Placement Of Shares For USD 11 Million 16

Acquisition 17

Stentys Acquire Minvasys for USD9.2 Million 17

Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18

Stentys SA-Key Competitors 19

Stentys SA-Key Employees 20

Stentys SA-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Financial Announcements 22

Oct 11, 2018: STENTYS: Financial Information for the Third Quarter of 2018 22

Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 23

Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 24

Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 25

Oct 02, 2017: STENTYS: 2017 half-year results 26

Jul 12, 2017: STENTYS: Revenues Of EUR1.7 Million in the Second Quarter Of 2017 27

Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 28

Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at EUR7.3 Million 29

Corporate Communications 30

Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 30

Product News 31

May 24, 2017: STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Stentys SA, Medical Equipment, Key Facts, 2017 2

Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Deals By Market, 2012 to YTD 2018 8

Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Stentys Enters into Distribution Agreement with Micell for MiStent SES 10

Stentys Raises USD14.6 Million in Rights Offering of Shares 11

Stentys Raises USD14.3 Million in Rights Offering of Shares 12

Stentys Announced Private Placement Of Shares 14

Stentys Completes Rights Issue Of Shares For USD 47.3 Million 15

Stentys Completes Private Placement Of Shares For USD 11 Million 16

Stentys Acquire Minvasys for USD9.2 Million 17

Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18

Stentys SA, Key Competitors 19

Stentys SA, Key Employees 20

Stentys SA, Subsidiaries 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Stentys SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.